Man hospitalized with respiratory depression after eating gas station CBD gummies

A 56-year-old man experienced respiratory depression, bradycardia, and obtundation after consuming 370mg of CBD gummies purchased at a gas station, requiring overnight hospital monitoring and raising concerns about unregulated CBD product safety.

Bass, Jessica et al.·Cureus·2020·Preliminary EvidenceCase Report
RTHC-02410Case ReportPreliminary Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

After consuming 370mg of CBD gummies (from two packages, well above the 30mg serving size), the patient developed slurred speech, vomiting, respiratory depression (O2 sat 78-84%), sinus bradycardia (HR 47), and hypotension (BP 88/52). Comprehensive urine toxicology was negative. He required continuous stimulation to maintain a patent airway and recovered fully by the next morning.

Key Numbers

370mg CBD consumed (two packages). Serving size listed as 30mg. O2 dropped to 78%. Heart rate dropped to 47. Blood pressure 88/52. Full recovery by next morning.

How They Did This

Single case report of a 56-year-old male with no prior substance abuse or significant medical history.

Why This Research Matters

CBD products sold at gas stations and convenience stores are unregulated, with unknown purity and potential contamination. This case shows serious adverse effects from a product the patient believed was safe.

The Bigger Picture

The case raises questions about whether the CBD gummies actually contained only CBD, or if they were contaminated with synthetic cannabinoids or other adulterants, which would not appear on standard toxicology screens.

What This Study Doesn't Tell Us

Single case report. Product contents were not independently verified. The toxicology was only for standard substances and may have missed novel adulterants.

Questions This Raises

  • ?Was the product actually pure CBD, or was it adulterated?
  • ?Should unregulated CBD products be subject to mandatory testing?

Trust & Context

Key Stat:
O2 dropped to 78% from gas station CBD gummies
Evidence Grade:
Single case report with no independent product verification.
Study Age:
2020 case report.
Original Title:
A Case of Toxicity from Cannabidiol Gummy Ingestion.
Published In:
Cureus, 12(4), e7688 (2020)
Database ID:
RTHC-02410

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

Can CBD gummies be dangerous?

This case showed a man developing respiratory depression and dangerous vital sign changes from gas station CBD gummies. The product was unregulated and its actual contents were unknown.

Are gas station CBD products safe?

This case raises serious concerns. The patient consumed 370mg from a product with a 30mg serving size and experienced life-threatening symptoms, possibly from impurity or adulteration.

Read More on RethinkTHC

Cite This Study

RTHC-02410·https://rethinkthc.com/research/RTHC-02410

APA

Bass, Jessica; Linz, David R. (2020). A Case of Toxicity from Cannabidiol Gummy Ingestion.. Cureus, 12(4), e7688. https://doi.org/10.7759/cureus.7688

MLA

Bass, Jessica, et al. "A Case of Toxicity from Cannabidiol Gummy Ingestion.." Cureus, 2020. https://doi.org/10.7759/cureus.7688

RethinkTHC

RethinkTHC Research Database. "A Case of Toxicity from Cannabidiol Gummy Ingestion." RTHC-02410. Retrieved from https://rethinkthc.com/research/bass-2020-a-case-of-toxicity

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.